ストックスクリーナーアプリを入手
0.99
12.39%
-0.14
前日終値:
$1.13
開ける：
$1.08
24時間の取引高:
829.19K
Relative Volume:
4.74
時価総額：
$4.40M
収益：
$72,100
当期純損益:
$-3.60M
株価収益率:
-0.5893
EPS:
-1.68
ネットキャッシュフロー:
$-3.37M
1週間 パフォーマンス:
-25.00%
1か月 パフォーマンス:
-18.18%
6か月 パフォーマンス:
-50.75%
1年 パフォーマンス:
-37.58%
1日の値動き範囲:
$0.98
$1.10
1週間の範囲:
$0.98
$1.34
52週間の値動き範囲:
$0.841
$4.50
Silo Pharma Inc Stock (SILO) Company Profile
SILO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| SILO | 1.56 | 17.96M | 0 | 0 | 0 | 0.00 |
| GOODO | 22.16 | 372.90M | 0 | 0 | 0 | 0.00 |
| PSNYW | 0.141 | 297.56M | 2.07B | -1.42B | -1.37B | -0.1344 |
| MOBBW | 0.16 | 278.60M | 0 | 0 | 0 | 0.00 |
| SHMD | 2.61 | 114.98M | 0 | 0 | 0 | 0.00 |
| JUNE | 4.95 | 63.87M | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc (SILO) 最新ニュース
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders - The Manila Times
Silo Pharma reports progress in PTSD treatment study - Investing.com
Silo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023) - Yahoo Finance
SILOSilo Pharma, Inc. Latest Stock News & Market Updates - StockTitan
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - GlobeNewswire
Silo Pharma, Inc. Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - Marketscreener.com
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
Orange Juice (OJX25) Quote - The Globe and Mail
Japan Ice Bank Silo Market By Application - Third Eye News
SILO Pharma (NASDAQ:SILO) Stock Quotes, Forecast and News Summary - Benzinga
Exclusive Come Home Trailer Previews Horror Thriller Movie Featuring Silo Stars - ComingSoon.net
Egypt: General Company for Silos’s profits rise 45.6% YoY in FY2023/24 - ZAWYA
Silvis Materials Awarded $1 Million NSF SBIR Phase II Grant to Reduce Emissions in Packaging and Building - EIN News
FDA Grants Accelerated Approval to Gilead’s Livdelzi for Primary Biliary Cholangitis - The Healthcare Technology Report.
Serpin Pharma and Uniklinikum Erlangen Team Up for a Clinical Trial to Prevent Acute Kidney Injury - EIN News
New Silo Season 2 Character Is Very Closely Copying An Iconic 2000s TV Show - Screen Rant
Roli Mosimann (Swans / Wiseblood / The The) has died - Brooklyn Vegan
SosMula Finally Delivers "SLEEZ RELIGION" - HotNewHipHop
Silo season 2: Apple TV Plus release date, likely cast, story rumors, and more news about the sci-fi show's return - TechRadar
Silo Pharma completes pre-IND meeting with FDA on SPC-15 for PTSD - BioWorld Online
Financial Metrics Exploration: Understanding SILO Pharma Inc (SILO) Through Ratios - The Dwinnex
SILO Pharma Inc [SILO] Insider Activity: An Update for Investors - Knox Daily
Silo Pharma moves forward with PTSD treatment SPC-15 - Investing.com
Silo Pharma moves forward with PTSD treatment SPC-15 By Investing.com - Investing.com Australia
SILO Pharma Inc Inc. (SILO) Price Performance: A Technical Analysis Perspective - The InvestChronicle
SILO’s price-to-sales ratio: Is it a good investment opportunity? - US Post News
Silo Pharma Outlines Strategic Direction and Innovative Pipeline - TipRanks
Silo Pharma Announces Completion of FDA Pre-IND Meeting to - GlobeNewswire
Psychedelic Drugs Market to Grow by USD 1.37 Billion from 2024-2028, Driven by Increasing Mental Health Disorders, Report Highlights AI's Impact on the Market LandscapeTechnavio - The Malaysian Reserve
Silo Pharma (NASDAQ:SILO) Shares Down 6% - Defense World
Adversity is less terrifying than hope: SILO Pharma Inc (SILO) - SETE News
SILO Pharma Inc (SILO)’s stock price range in the last year - US Post News
Metric Deep Dive: Understanding SILO Pharma Inc (SILO) Through its Ratios - The Dwinnex
SILO Pharma Inc [SILO] Investment Guide: What You Need to Know - Knox Daily
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million - Quantisnow
SILO’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Silo Pharma advances ketamine implant for chronic pain treatment - Investing.com India
Silo Pharma Shares Jump 11% on Ketamine-Treatment Partnership - MarketWatch
Silo Pharma advances ketamine implant for chronic pain treatment By Investing.com - Investing.com UK
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic - GlobeNewswire
SILO Pharma Inc’s latest rating changes from various analysts - Knox Daily
Silo Pharma partners with WuXi AppTec for MS peptide study - Investing.com India
Closing Figures: SILO Pharma Inc (SILO)’s Negative Finish at 1.18, Down -13.24 - The Dwinnex
Silo Pharma partners with WuXi AppTec for MS peptide study By Investing.com - Investing.com UK
SILO’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
How does SILO’s price to cash per share ratio compare in the market? - US Post News
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide - GlobeNewswire
Taking on analysts’ expectations and winning: SILO Pharma Inc (SILO) - SETE News
Examining SILO Pharma Inc (SILO) more closely is necessary - US Post News
Investing in SILO Pharma Inc (SILO): What You Must Know - Knox Daily
SILO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Silo Pharma Inc (SILO) 財務データ
収益
当期純利益
現金流量
EPS
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):